Pesquisar um medicamento órfão
Outras opções de pesquisa
96 Resultado(s)
Medicamento(s)
- (1S, 2S, 3R, 4R)-3-(5-Fluoro-2-(3-methyl-4-(4-methylpiperazin-1-yl)-phenylamino)- pyrimidin-4-ylamino)-bicyclo[2.2.1]hept-5-ene-2-carboxamide benzoate)
- (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl) amino)methyl)tetrahydrofuran-3,4-diol
- (S)-5-(1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
- (Z)-3-(3-(3,5-bis(trifluorometil)fenil-1H-1,2,4-triazol-1-il)-N'-(pirazin-2-il)acrilhidrazida
- 1,2-bis(methylsulphonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine
- 1-(4-{4-amino-7-[1-(2-hidroxietil)-1H- pirazol-4-il]tieno[3,2-c]piridina-3-il}fenil)-3-(3-fluorofenil)ureia
- 1-[2-(Benzo[1,2,5]tiadiazol-5-ilamino)-6-(2,6-dicloro-fenil)-pirido[2,3-d]pirimidin-7-il]-3-terc-butil-ureia
- 1-ciclopropil-3-[3-(5-morfolin-4-ilmetil-1H-benzoimidazol-2-il)-1H-pirazol-4-il]-ureia
- 2-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-N-((5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)acetamide, tetrahydrochloride
- 2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thienol[3,2,-f]-[1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)-acetamide dihydrate
- 2-[[3-({4-[(5-{2-[(3-Fluorofenil)amino]-2-oxoetil}-1H-pirazol-3-yl)amino]-quinazolina-7-yl}oxi)propil](etil)amino]etil dihidrogenofosfato trihidratado
- 2-hydroxymethyl-2-methoxymethyl-1-azabicyclo[2,2,2]octan-3-one
- 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol methanesulfonate
- 225Ac-lintuzumab
- 5'-O-(trans-9"-octadecenoyl)-1-ß-D-arabinofuranosyl cytosine
- 6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one monocitrate
- Allogeneic ex vivo-generated natural killer cells from CD34+ umbilical cord blood progenitor cells
- Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus
- Allogeneic, umbilical cord blood-derived, ex vivo-expanded, haematopoietic CD133+ cells / allogeneic, umbilical cord blood-derived, non-expanded, haematopoietic CD133- cells
- Alogênico células dendríticas derivadas de uma linhagem de células CD34 + progenitoras
- Alvocidib
- Amonafide L-malate
- Antisense oligonucleotide 5'-d[P-Thio} (CCCTG CTCCC CCCTG GCTCC)-3'
- Azacitidine
- Bisantrene hydrochloride
- Clofarabine
- Cloridrato de N-[(2S)-2,3-dihidroxipropil]-3-[(2-fluoro-4-iodofenil) amino] isonicotinamida
- Combretastatin A1 diphosphate-
- Crenolanib
- Células alogénicas do sangue do cordão umbilical expandidas ex vivo
- Células estaminais de medula óssea alogénicas tratadas ex vivo com 16,16-dimetilprostaglandina E2
- Células sanguíneas de cordão umbilical alogénicas tratadas ex vivo com 16,16-dimetilprostaglandina E2
- Daunorubicin (liposomal)
- Decitabina
- Devimistat
- Di-cloridrato de N-(5-ter-butilisoxazol-3-il)-N'-{4-[7-(2-(morfolin-4-il)etoxi)imidazol [2,1-b][1,3]benzotiazol-2-il]fenil}ureia
- Donor lymphocyte preparation depleted of functional alloreactive T-cells
- Fully human IgG1 antibody specific for CD33
- Gemtuzumab ozogamicin
- Gilteritinib
- Histamine dihydrochloride
- Histona recombinante humana H1.3 e N-bis-met-Histona recombinante humana H1.3 tipo
- Homoharringtonine
- Human monoclonal antibody against inhibitory killer cell lg-like receptors (1-7 F9)
- Inecalcitol
- Isocitrate dehydrogenase 2-mutant inhibitor
- Ivosidenib
- L-Asparaginase
- L-asparaginase encapsulada em eritrócitos
- Laromustine
- Lestaurtinib
- Linfócitos T alogénicos com um gene TK exógeno
- Lintuzumab
- Liposomal cytarabine-daunorubicin
- Liposomal daunorubicin
- Midostaurina
- Mitoxantrona
- N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide
- NEDD8-activating enzyme (NAE) inhibitor
- Oligonucleotido de DNA fosfodiester monocatenado singola com 26 bases
- Onvansertib
- P-ethoxy growth factor receptor-bound protein 2 (Grb2) antisense oligonucleotide
- Plerixafor
- Pracinostat
- Recombinant human interleukin-3 truncated diphtheria toxin fusion protein
- Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide
- Sapacitabine
- Sodium (2R,3S,5R)-5-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)-2-(hydroxymethyl)tetrahydrofuran-3-yl ((2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate
- Tamibaroteno
- Tipifarnib
- Tosedostat
- Trans N1-((1R,2S)-2-fenil-ciclopropil)-ciclohexano-1, 4-diamina bis-cloridrato
- Trióxido de arsénico
- Troxacitabina
- Ulocuplumab
- Vadastuximab talirine
- Val-Leu-Gln-Glu-Leu-Asn-Val-Thr-Val (Pr1 nanopeptide, sequence 169-177, of proteinase 3)
- Venetoclax
- Volasertib
- Vosaroxina
- Wilms' tumour 1 (WT1) vaccine
- Zosuquidar trihydrochloride
- cusatuzumab
- haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate
- humanised monoclonal antibody of the IgG4 kappa isotype targeting CD47
- Ácido 4-{[(2R,3S,4R,5S)-4-(4-cloro-2-fluoro-fenil)-3-(3-cloro-2-fluoro-fenil)-4-ciano-5-(2,2-dimetil-propil)-pirrolidina-2-carbonil]-amino}-3-metoxi-benzóico